Souzan Sanati MD
Cytopathology, Anatomic Pathology, Clinical Pathology, Surgical Pathology
Assistant Professor, Pathology & Immunology, Washington University School of Medicine
Join to View Full Profile
8700 Beverly Blvd# SB290West Hollywood, CA 90048
Phone+1 310-248-6240
Fax+1 310-439-1906
Dr. Sanati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Gynecologic Pathology, 2008 - 2009
Washington University/B-JH/SLCH ConsortiumFellowship, Cytopathology, 2006 - 2007- Washington University/B-JH/SLCH Consortium Gynecologic and Breast PathologyFellowship, Selective Pathology, 2005 - 2006
University of Texas Medical Branch HospitalsResidency, Pathology-Anatomic and Clinical, 2001 - 2005
Iran University of Medical SciencesClass of 1993
Certifications & Licensure
CA State Medical License 2015 - 2025
IL State Medical License 2016 - 2020
MO State Medical License 2007 - 2020
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Cytopathology
Clinical Trials
- PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer Start of enrollment: 2013 Apr 10
- Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer Start of enrollment: 2014 Aug 01
- Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer Start of enrollment: 2014 Apr 02
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsEndocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or...Cynthia X Ma, Vera J Suman, Souzan Sanati, Kiran Vij, Meenakshi Anurag
JAMA Oncology. 2024-03-01 - 23 citationsInterobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association w...Mieke R Van Bockstal, Aline François, Serdar Altinay, Laurent Arnould, Maschenka Balkenhol
Modern Pathology. 2021-07-03 - 11 citationsEarly Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical TomographyQuing Zhu, Foluso O. Ademuyiwa, Catherine A. Young, Catherine M. Appleton, Matthew F. Covington
Breast Cancer Research and Treatment. 2021-05-10
Journal Articles
- Proteogenomic Integration Reveals Therapeutic Targets in Breast Cancer XenograftsSouzan Sanati, Jana W Qiao, Xian Chen, Matthew J Ellis, Cynthia Ma, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
